Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06490328 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06490328 · ClinicalTrials.gov record · last posted 2026-08-14

Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

StatusCompleted
PhasePhase 3
Started2024-05-30
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
A phase 3, multi-center, single-group, open-label study to evaluate the efficacy and safety of DKF-MA102 in patients with prostate cancer.

Protocol amendment history 5 changes detected by DataLookout

2026-08-15
Trial status changed: Unknown → Completed
2026-08-15
Trial sites expanded: 1 → 8 locations
2026-08-15
Primary completion pushed: 2025-05-20 → 2026-01-21
2026-08-15
Completion pushed: 2025-05-20 → 2026-03-09
2026-08-02
Trial status changed: Recruiting → Unknown
Trial Details
NCT Number NCT06490328
Lead Sponsor Dongkook Pharmaceutical Co., Ltd.
Conditions Advanced Prostate Cancer
Enrollment 161 participants
Start Date 2024-05-30
Primary Completion 2026-01-21 (estimated)
Study Completion 2026-03-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-14